RAVENNA, Italy–(BUSINESS WIRE)–Ravenna, città del mosaico, riconosciuta Patrimonio Mondiale dall’UNESCO, permette ai visitatori daltonici di riscoprire i colori dei mosaici
Author: Business Wire
Harrow to Attend 2024 ASRS Annual Meeting
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that its management team would attend the 2024 American Society of Retina Specialists (ASRS) Annual Meeting, ta…
Merck Completes Acquisition of EyeBio
RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Eyebiotech Limited (EyeBio). EyeBio is now a wholly-owned subsidiary of Merck. “The EyeBio acqu…
Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on Wednesday, July 31, 2024…
Ophthalmics Partnering Agreements Analysis Report and Directory 2019-2024: Collaboration, Development, Research and Licensing Deals by Company A-Z, Deal Type and Therapy Area – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmics Collaboration and Licensing Deals 2019-2024” report has been added to ResearchAndMarkets.com’s offering. Fully revised and updated, the report provides details of ophthalmics deals from 2019 to 2024. Ophthalmic…
Castle Biosciences Honored with Top Workplaces Awards
FRIENDSWOOD, Texas–(BUSINESS WIRE)—- $CSTL #CastleBiosciences–Castle honored as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards
NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”) announces preliminary net revenue for the second quarter of 2024 of $2.4 million and for the first half of 2024 of $5.0 million, primar…
GenSight Biologics Launches Newsletter for Retail Investors
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics lance une lettre d'information pour les investisseurs particuliers
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurod…
Kopin Hosts ‘Vision System Demo Days’ Event in NYC to Unveil and Showcase Transformative Wearable Vision and Software Solutions for Defense, Medical and Consumer Applications
WESTBOROUGH, Mass.–(BUSINESS WIRE)–Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical solutions and high-performance micro-displays, announced today its upcoming Vision System Demo Days event, scheduled for July 16-1…
Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release secon…
DocGo and Spect Partner to Reduce Care Gaps and Improve Eye and Vision Health
NEW YORK–(BUSINESS WIRE)–DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health services, today announced its partnership with Spect, a leading provider of comprehensive digital services for eye e…
Harrow Enters into 340B Prime Vendor Program Contract with Apexus™ for IHEEZO® and Other Key Harrow Products
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that as of July 1, 2024, it has entered into an agreement with Apexus to make IHEEZO® (chloroprocaine hydrochlo…
Genentech to Reintroduce Susvimo for People With Wet Age-related Macular Degeneration (AMD)
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant for the treatmen…
Ophthalmic Devices Analysis Report 2024-2032: $10.22 Bn Market by Diagnostic & Monitoring Devices, Surgical Devices, Vision Correction Devices, Application, End User, Regions and Company Landscape – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market Report by Diagnostic & Monitoring Devices, Surgical Devices, Vision Correction Devices, Application, End User, Regions and Company Analysis 2024-2032” report has been added to ResearchAndMarke…
o9 Partners With CooperVision To Support Strategic Initiative For Accelerating Supply Chain Operations
DALLAS–(BUSINESS WIRE)–o9, a leading enterprise AI software platform provider for transforming planning and decision-making, today announced that CooperVision, one of the world’s leading manufacturers of contact lenses, has selected the o9 Digital Br…
Charles River to Perform Plasmid Manufacturing for AAVantgarde
WILMINGTON, Mass.–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) and AAVantgarde today announced a contract development and manufacturing organization (CDMO) agreement to produce Good Manufacturing Practice- (GMP) plasmid …
Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today shared results from the company’s inaugural State of Dry Eye survey, which e…
FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. Food and Drug Administration (FDA) has approved the Vabysmo® (faricimab-svoa) 6.0 mg single-dose prefilled syring…
Global Eyewear Market Forecasted to Attain $270 Billion Valuation by 2032: Market Growth Propelled by Technological Innovations and Rising Health Awareness – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market Product, End User, Distribution Channel, Regions and Company Analysis 2024-2032” report has been added to ResearchAndMarkets.com’s offering. The eyewear market is experiencing a significant growth trajectory…